Similar articles

• Neurologic deficit following spinal anesthesia.

  Schou H, Hole P. Schou H, et al. Acta Anaesthesiol Belg. 1987;38(3):241-3. Acta Anaesthesiol Belg. 1987. PMID: 3425215
• Possible malignant hyperthermia during spinal anaesthesia with tetracaine.

  Sheu CC, Tsai JR, Hung JY. Sheu CC, et al. Anaesthesia. 2007 Feb;62(2):200-1. doi: 10.1111/j.1365-2044.2007.04969.x. Anaesthesia. 2007. PMID: 17223832 No abstract available.
• A prospective multicenter trial to determine the incidence of transient neurologic symptoms after spinal anesthesia with phenylephrine added to 0.5% tetracaine.

  Maehara Y, Kusunoki S, Kawamoto M, Yuge O, Okida M, Kinoshita H, Nakagawa I, Nakao M, Sasaki H. Maehara Y, et al. Hiroshima J Med Sci. 2001 Jun;50(2):47-51. Hiroshima J Med Sci. 2001. PMID: 11480461 Clinical Trial.
• AANA Journal course: transient neurologic symptoms and spinal anesthesia.

  Sime AC. Sime AC. AANA J. 2000 Apr;68(2):163-8. AANA J. 2000. PMID: 10876464 Review.
• Clinical physiology of dopa dyskinesia.

  Hallett M. Hallett M. Ann Neurol. 2000 Apr;47(4 Suppl 1):S147-50; discussion S150-3. Ann Neurol. 2000. PMID: 10762142 Review.